Safety of hydroxychloroquine in COVID-19 and other diseases: a systematic review and meta-analysis of 53 randomized trials

INTRODUCTION: Many concerns still exist regarding the safety of hydroxychloroquine (HCQ) in the treatment of Coronavirus Disease 2019 (COVID-19). OBJECTIVES: The purpose of this study was to evaluate the safety of HCQ in the treatment of COVID-19 and other diseases by performing a systematic review...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Can, Pan, Kunming, Wu, Bingjie, Li, Xiaoye, Chen, Zhangzhang, Xu, Qing, Li, Xiaoyu, Lv, Qianzhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417776/
https://www.ncbi.nlm.nih.gov/pubmed/32780229
http://dx.doi.org/10.1007/s00228-020-02962-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417776/
https://www.ncbi.nlm.nih.gov/pubmed/32780229
http://dx.doi.org/10.1007/s00228-020-02962-5

Ejemplares similares